The effect of erythropoietin on autologous stem cell-mediated bone regeneration

Ashwin M. Nair, Yi Ting Tsai, Krishna M. Shah, Jinhui Shen, Hong Weng, Jun Zhou, Xiankai Sun, Ramesh Saxena, Joseph Borrelli, Liping Tang

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) although used for bone tissue engineering are limited by the requirement of isolation and culture prior to transplantation. Our recent studies have shown that biomaterial implants can be engineered to facilitate the recruitment of MSCs. In this study, we explore the ability of these implants to direct the recruitment and the differentiation of MSCs in the setting of a bone defect. We initially determined that both stromal derived factor-1alpha (SDF-1α) and erythropoietin (Epo) prompted different degrees of MSC recruitment. Additionally, we found that Epo and bone morphogenetic protein-2 (BMP-2), but not SDF-1α, triggered the osteogenic differentiation of MSCs invitro. We then investigated the possibility of directing autologous MSC-mediated bone regeneration using a murine calvaria model. Consistent with our invitro observations, Epo-releasing scaffolds were found to be more potent in bridging the defect than BMP-2 loaded scaffolds, as determined by computed tomography (CT) scanning, fluorescent imaging and histological analyses. These results demonstrate the tremendous potential, directing the recruitment and differentiation of autologous MSCs has in the field of tissue regeneration.

Original languageEnglish (US)
Pages (from-to)7364-7371
Number of pages8
JournalBiomaterials
Volume34
Issue number30
DOIs
StatePublished - Oct 2013

Fingerprint

Bone Regeneration
Erythropoietin
Stem cells
Mesenchymal Stromal Cells
Bone
Stem Cells
Bone Morphogenetic Protein 2
Scaffolds
Proteins
Bone and Bones
Tissue regeneration
Defects
Biocompatible Materials
Tissue Engineering
Scaffolds (biology)
Tissue engineering
Skull
Biomaterials
Tomography
Regeneration

Keywords

  • Autologous stem cells
  • Bone morphogenetic protein-2
  • Bone tissue engineering
  • Erythropoietin
  • Scaffold
  • Stromal derived factor-1α

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Nair, A. M., Tsai, Y. T., Shah, K. M., Shen, J., Weng, H., Zhou, J., ... Tang, L. (2013). The effect of erythropoietin on autologous stem cell-mediated bone regeneration. Biomaterials, 34(30), 7364-7371. https://doi.org/10.1016/j.biomaterials.2013.06.031

The effect of erythropoietin on autologous stem cell-mediated bone regeneration. / Nair, Ashwin M.; Tsai, Yi Ting; Shah, Krishna M.; Shen, Jinhui; Weng, Hong; Zhou, Jun; Sun, Xiankai; Saxena, Ramesh; Borrelli, Joseph; Tang, Liping.

In: Biomaterials, Vol. 34, No. 30, 10.2013, p. 7364-7371.

Research output: Contribution to journalArticle

Nair, AM, Tsai, YT, Shah, KM, Shen, J, Weng, H, Zhou, J, Sun, X, Saxena, R, Borrelli, J & Tang, L 2013, 'The effect of erythropoietin on autologous stem cell-mediated bone regeneration', Biomaterials, vol. 34, no. 30, pp. 7364-7371. https://doi.org/10.1016/j.biomaterials.2013.06.031
Nair, Ashwin M. ; Tsai, Yi Ting ; Shah, Krishna M. ; Shen, Jinhui ; Weng, Hong ; Zhou, Jun ; Sun, Xiankai ; Saxena, Ramesh ; Borrelli, Joseph ; Tang, Liping. / The effect of erythropoietin on autologous stem cell-mediated bone regeneration. In: Biomaterials. 2013 ; Vol. 34, No. 30. pp. 7364-7371.
@article{f7343927a5194fb3909bc64eaa4bbb97,
title = "The effect of erythropoietin on autologous stem cell-mediated bone regeneration",
abstract = "Mesenchymal stem cells (MSCs) although used for bone tissue engineering are limited by the requirement of isolation and culture prior to transplantation. Our recent studies have shown that biomaterial implants can be engineered to facilitate the recruitment of MSCs. In this study, we explore the ability of these implants to direct the recruitment and the differentiation of MSCs in the setting of a bone defect. We initially determined that both stromal derived factor-1alpha (SDF-1α) and erythropoietin (Epo) prompted different degrees of MSC recruitment. Additionally, we found that Epo and bone morphogenetic protein-2 (BMP-2), but not SDF-1α, triggered the osteogenic differentiation of MSCs invitro. We then investigated the possibility of directing autologous MSC-mediated bone regeneration using a murine calvaria model. Consistent with our invitro observations, Epo-releasing scaffolds were found to be more potent in bridging the defect than BMP-2 loaded scaffolds, as determined by computed tomography (CT) scanning, fluorescent imaging and histological analyses. These results demonstrate the tremendous potential, directing the recruitment and differentiation of autologous MSCs has in the field of tissue regeneration.",
keywords = "Autologous stem cells, Bone morphogenetic protein-2, Bone tissue engineering, Erythropoietin, Scaffold, Stromal derived factor-1α",
author = "Nair, {Ashwin M.} and Tsai, {Yi Ting} and Shah, {Krishna M.} and Jinhui Shen and Hong Weng and Jun Zhou and Xiankai Sun and Ramesh Saxena and Joseph Borrelli and Liping Tang",
year = "2013",
month = "10",
doi = "10.1016/j.biomaterials.2013.06.031",
language = "English (US)",
volume = "34",
pages = "7364--7371",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "30",

}

TY - JOUR

T1 - The effect of erythropoietin on autologous stem cell-mediated bone regeneration

AU - Nair, Ashwin M.

AU - Tsai, Yi Ting

AU - Shah, Krishna M.

AU - Shen, Jinhui

AU - Weng, Hong

AU - Zhou, Jun

AU - Sun, Xiankai

AU - Saxena, Ramesh

AU - Borrelli, Joseph

AU - Tang, Liping

PY - 2013/10

Y1 - 2013/10

N2 - Mesenchymal stem cells (MSCs) although used for bone tissue engineering are limited by the requirement of isolation and culture prior to transplantation. Our recent studies have shown that biomaterial implants can be engineered to facilitate the recruitment of MSCs. In this study, we explore the ability of these implants to direct the recruitment and the differentiation of MSCs in the setting of a bone defect. We initially determined that both stromal derived factor-1alpha (SDF-1α) and erythropoietin (Epo) prompted different degrees of MSC recruitment. Additionally, we found that Epo and bone morphogenetic protein-2 (BMP-2), but not SDF-1α, triggered the osteogenic differentiation of MSCs invitro. We then investigated the possibility of directing autologous MSC-mediated bone regeneration using a murine calvaria model. Consistent with our invitro observations, Epo-releasing scaffolds were found to be more potent in bridging the defect than BMP-2 loaded scaffolds, as determined by computed tomography (CT) scanning, fluorescent imaging and histological analyses. These results demonstrate the tremendous potential, directing the recruitment and differentiation of autologous MSCs has in the field of tissue regeneration.

AB - Mesenchymal stem cells (MSCs) although used for bone tissue engineering are limited by the requirement of isolation and culture prior to transplantation. Our recent studies have shown that biomaterial implants can be engineered to facilitate the recruitment of MSCs. In this study, we explore the ability of these implants to direct the recruitment and the differentiation of MSCs in the setting of a bone defect. We initially determined that both stromal derived factor-1alpha (SDF-1α) and erythropoietin (Epo) prompted different degrees of MSC recruitment. Additionally, we found that Epo and bone morphogenetic protein-2 (BMP-2), but not SDF-1α, triggered the osteogenic differentiation of MSCs invitro. We then investigated the possibility of directing autologous MSC-mediated bone regeneration using a murine calvaria model. Consistent with our invitro observations, Epo-releasing scaffolds were found to be more potent in bridging the defect than BMP-2 loaded scaffolds, as determined by computed tomography (CT) scanning, fluorescent imaging and histological analyses. These results demonstrate the tremendous potential, directing the recruitment and differentiation of autologous MSCs has in the field of tissue regeneration.

KW - Autologous stem cells

KW - Bone morphogenetic protein-2

KW - Bone tissue engineering

KW - Erythropoietin

KW - Scaffold

KW - Stromal derived factor-1α

UR - http://www.scopus.com/inward/record.url?scp=84880513358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880513358&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2013.06.031

DO - 10.1016/j.biomaterials.2013.06.031

M3 - Article

C2 - 23831188

AN - SCOPUS:84880513358

VL - 34

SP - 7364

EP - 7371

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 30

ER -